The NFO is currently open for subscription and it will close on August 8.
“The Scheme enables investors to donate part of the income generated to the Indian Cancer Society to support the treatment of underprivileged cancer patients. The noble mission is to make a meaningful impact on the lives of those fighting this formidable battle. Together, as we invest in both financial growth and human well-being, we can create a future where hope and healing become accessible to all,” said Navneet Munot, Managing Director and Chief Executive Officer, HDFC Asset Management Company.
The scheme will offer investors the flexibility to choose either a 50% or 75% contribution of Income Distribution cum Capital Withdrawal (IDCW) to be donated to the ICS. HDFC AMC will match donations with an equal amount directly contributed to ICS (subject to a limit of Rs 16 crore per financial year). The AMC has waived all investment management and advisory fees for this scheme, ensuring that the maximum benefit goes towards supporting cancer patients in need.
“This scheme, a part of the series of Cancer Cure Funds, is making a significant difference in the lives of underprivileged cancer patients, empowering them with access to vital treatment and care. Through these initiatives, HDFC Mutual Fund is demonstrating its unwavering commitment to creating a positive social impact and fostering a better future for those affected by cancer,” said Usha Thorat, Honorary Secretary and Managing Trustee of the Indian Cancer Society.
This NFO is the 4th edition of the cancer cure series. Since its initial launch in 2011, the collective contribution from the series, including direct contribution from HDFC AMC, is nearly Rs 190 crore, making a big impact to thousands of lives.
